|
⚲
|
| Keyboard |
| Keros Therapeutics Inc | |
|---|---|
| Ticker | KROS |
| CIK # | 0001664710 |
| CUSIP | 492327101 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 99 Hayden Avenue, Suite 120 (Bld E) Ledgemont Technology Center, Lexington, MA 02421 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Keros Therapeutics Inc | 2020-03-12 | 56.0 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001664710] | 10-K | |
| [0001664710] | 10-Q | |
| [0001664710] | 3 | |
| [0001664710] | 4 | |
| [0001664710] | 8-K | |
| [0001664710] | D | |
| [0001664710] | SC 13D | |
| [0001664710] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Newton Charles W
Common Stock
|
2026-03-09 | Grant | 13,215 | $0.00 | |
|
Bienaime Jean Jacques
Common Stock
|
2026-03-09 | Buy | 2,000 | $11.21 | 22,420 |
|
Newton Charles W
Stock Option (Right to Buy) · derivative
|
2026-03-09 | Grant | 14,788 | $0.00 | |
|
Regnante Keith
Employee Stock Option (Right to Buy) · derivative
|
2026-02-24 | Grant | 60,000 | $0.00 | |
|
Lerner Lorena Raquel
Employee Stock Option (Right to Buy) · derivative
|
2026-02-24 | Grant | 75,000 | $0.00 | |
|
Employee Stock Option (Right to Buy) · derivative
|
2026-02-24 | Grant | 80,000 | $0.00 | |
|
Seehra Jasbir
Employee Stock Option (right to buy) · derivative
|
2026-02-24 | Grant | 100,000 | $0.00 | |
|
Cho Esther
Employee Stock Option (Right to Buy) · derivative
|
2026-02-24 | Grant | 80,000 | $0.00 | |
|
Seehra Jasbir
Employee Stock Option (Right to Buy) · derivative
|
2026-02-24 | Grant | 217,000 | $0.00 | |
|
Seehra Jasbir
Common Stock
|
2026-02-19 | Sell | 7,015 | $16.17 | 113,433 |
|
Regnante Keith
Common Stock
|
2026-02-18 | Sell | 4,739 | $16.35 | 77,483 |
|
Lerner Lorena Raquel
Common Stock
|
2026-02-18 | Sell | 3,873 | $16.35 | 63,324 |
|
Cho Esther
Common Stock
|
2026-02-18 | Sell | 4,745 | $16.35 | 77,581 |
|
Seehra Jasbir
Employee Stock Option (right to buy) · derivative
|
2026-01-07 | Grant | 62,500 | $0.00 | |
|
OrbiMed Genesis GP LLC +2
Common Stock
|
2025-11-21 | Disposed to issuer | 74,465 | $17.75 | 1,321,754 |
|
OrbiMed Genesis GP LLC +2
Common Stock
|
2025-11-21 | Disposed to issuer | 140,057 | $17.75 | 2,486,012 |
|
Knowles Julius
Common Stock
|
2025-11-21 | Disposed to issuer | 191,527 | $17.75 | 3,399,604 |
|
Knowles Julius
Common Stock
|
2025-11-21 | Disposed to issuer | 130,494 | $17.75 | 2,316,268 |
|
Gordon Carl L
Common Stock
|
2025-11-21 | Disposed to issuer | 74,465 | $17.75 | 1,321,754 |
|
Gordon Carl L
Common Stock
|
2025-11-21 | Disposed to issuer | 140,057 | $17.75 | 2,486,012 |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 151 | 18,668,438 |
| 2025-12-31 | 166 | 20,235,364 |
| 2025-09-30 | 156 | 36,247,920 |
| 2025-06-30 | 141 | 37,572,242 |
| 2025-03-31 | 159 | 38,962,114 |
| 2024-12-31 | 165 | 37,203,818 |
| 2024-09-30 | 166 | 33,562,395 |
| 2024-06-30 | 153 | 30,753,799 |
| 2024-03-31 | 149 | 30,901,408 |
| 2023-12-31 | 122 | 26,041,211 |
| 2023-09-30 | 108 | 21,683,906 |
| 2023-06-30 | 125 | 20,861,847 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Y-Intercept Hong Kong Ltd | [2026-06-30] | SOLE | 48,176 | 48,176 |
| Wealth Enhancement Advisory Services LLC | [2026-06-30] | SOLE | 443 | 17,841 |
| IFP Advisors LLC | [2026-06-30] | SOLE | 3,013 | 3,013 |
| Gamma Investing LLC | [2026-06-30] | DFND | 824 | 824 |
| Farther Finance Advisors LLC | [2026-06-30] | SOLE | 0 | 252 |
| Sachetta LLC | [2026-06-30] | SOLE | 0 | 244 |
| True Wealth Design LLC | [2026-06-30] | SOLE | 0 | 160 |
| Owl Creek Wealth Partners LLC | [2026-06-30] | SOLE | 0 | 100 |
| Capital Advisors Ltd LLC | [2026-06-30] | SOLE | 0 | 30 | Prev | Page 1 | Next |